AI Maverick Intel, Inc. (BINP)
OTCMKTS · Delayed Price · Currency is USD
0.0370
-0.0010 (-2.63%)
Jul 17, 2025, 9:30 AM EDT
AI Maverick Intel Revenue
In the year 2013, AI Maverick Intel had annual revenue of $92.26K.
Revenue
92.26K
Revenue Growth
n/a
P/S Ratio
22.24
Revenue / Employee
18.45K
Employees
5
Market Cap
2.05M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |
AI Maverick Intel News
- 7 weeks ago - Bionoid Pharma, Inc. Confirms Name Change to AI Maverick Intel, Inc. Following Delaware Approval - Accesswire
- 2 months ago - Bionoid Pharma, Inc. Rebrands as AI Maverick Intel, Inc. to Reflect Strategic Shift Toward AI-Driven Innovation - Accesswire
- 3 months ago - Bionoid Pharma Inc. Announces Completion of 2024 Financial Audit - Accesswire
- 3 months ago - Bionoid Pharma Inc. Engages Aloba, Awomolo & Partners as External Auditor for 2024 Financial Statements - Accesswire
- 4 months ago - Bionoid Pharma Announces Filing of OTCQB Application to Enhance Market Visibility and Liquidity - Accesswire
- 4 months ago - Bionoid Pharma, Inc. Announces Completion of 2022 and 2023 Financial Audits by PCAOB-Registered Firm - Accesswire
- 6 months ago - Bionoid Pharma, Inc. Provides Corporate Update and Outlines Growth Strategy for 2025 - Accesswire
- 6 months ago - Bionoid Pharma, Inc. Reports Over $100,000 in Revenue Following Binding LOI With Your Supplement Supply Store Ltd. - Accesswire